Experimental group | TG (mg/dL) | TC (mg/dL) | HDL (mg/dL) | LDL (mg/dL) | VLDL (mg/dL) |
---|---|---|---|---|---|
Normal control | 85.00 ± 3.20 | 73.83 ± 4.35 | 15.50 ± 0.57 | 41.34 ± 4.45 | 17.00 ± 0.64 |
Diabetic control | 219.5 ± 7.66* | 133.5 ± 3.15* | 11.46 ± 1.31 | 78.14 ± 4.61* | 43.9 ± 1.53* |
STZ + 0.5 mg/kg glibenclamide | 104.17 ± 3.48** | 71 ± 3.53** | 20.26 ± 1.23** | 29.91 ± 4.00** | 20.83 ± 0.70** |
STZ + 50 mg/kg GME | 159.67 ± 5.23** | 92 ± 2.32** | 13.42 ± 1.28 | 46.65 ± 3.47** | 31.93 ± 1.05** |
STZ + 100 mg/kg GME | 131.67 ± 5.37** | 91.5 ± 2.17** | 12.92 ± 1.02 | 52.25 ± 2.20** | 26.33 ± 1.07** |
STZ + 200 mg/kg GME | 133.17 ± 3.40** | 73.67 ± 4.06** | 15.5 ± 1.20 | 31.53 ± 4.34** | 26.63 ± 0.68** |